Iceotope | $26,000,000 | (May 15, 2026)
Harken Sweets | Undisclosed Amount | (May 15, 2026)
Graphon AI | $8,300,000 | (May 15, 2026)
Certified by Founder
Lodge
Syremis Therapeutics
start up
- 19/12/2025
- Series A
- $165,000,000
Syremis Therapeutics is a clinical-stage biopharmaceutical company developing novel medicines to make a profound impact on the treatment of mental health. The company’s neuropsychiatric pipeline is rooted in emerging and clinically validated mechanisms, including muscarinic M1/M4 agonism and next-generation NMDA antagonism.
- Industry Biotechnology Research
- Website https://syremis.com/
- LinkedIn https://www.linkedin.com/company/syremis-therapeutics/
Related People
Elisabeth KoganFounder
Israel -
ND
CEO and Co-founder of Syremis Therapeutics, a Biotech company developing novel therapies for neuropsychiatric conditions.
Experienced Pharma executive with a successful track record of delivering innovation and growth in the pharmaceutical industry.
Passionate about bringing new solutions to patients to reduce suffering and improve quality of life.
Ranger AI | $8,400,000 | (May 15, 2026)
GridCARE | $64,000,000 | (May 15, 2026)
Chromie Health | $2,000,000 | (May 15, 2026)
Novella | $21,000,000 | (May 15, 2026)
Flick | $6,000,000 | (May 15, 2026)
Synthetic | $10,000,000 | (May 14, 2026)
SwishX | $2,200,000 | (May 14, 2026)
Urologic Health | $11,000,000 | (May 14, 2026)